Agenus Inc. Watch

from 8-K 17 pages Form of 2024 a Warrant

from S-3ASR 51 pages Agenus Inc. and [ ], as Trustee Indenture Dated as of [ ], [ ]

from 10-K 4 pages Amendment to Notes, Termination of Warrants and Sale of New Warrants

from S-3ASR 6 pages Amendment to Notes, Termination of Warrants and Sale of New Warrants

from 8-K 16 pages Form of 2022 B Warrant

from 8-K 16 pages Form of 2022 a Warrant

from 10-Q 34 pages Stock Purchase Agreement

from S-3ASR 51 pages Agenus Inc. and [ ], as Trustee Indenture Dated as of [ ], [ ]

from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934

from 10-K 15 pages This Warrant and the Securities Issuable Upon Exercise of This Warrant Have Not Been Registered Under the Securities Act of 1933, as Amended (The “Act”), or Qualified Under Any State or Foreign Securities Laws and May Not Be Offered for Sale, Sold, Pledged, Hypothecated or Otherwise Transferred or Assigned Unless (I) a Registration Statement Covering Such Shares Is Effective Under the Act and Is Qualified Under Applicable State and Foreign Law or (II) the Transaction Is Exempt From the Registration and Prospectus Delivery Requirements Under the Act and the Qualification Requirements Under Applicable State and Foreign Law And, if the Corporation Requests, an Opinion Satisfactory to the Corporation to Such Effect Has Been Rendered by Counsel. Warrant Certificate No.: Original Issue Date: February 18, 2020

from 10-K 3 pages Amendment to Notes and Warrants and Sale of New Warrants

from S-8 12 pages Agenus Inc. 2019 Employee Stock Purchase Plan

from 10-K 23 pages Agenus Inc. Common Stock Purchase Agreement

from 10-Q 41 pages Royalty Purchase Agreement Dated as of September 20, 2018 Among Agenus Royalty Fund, LLC as Seller, Agenus Inc. as Seller Parent and Xoma (US) LLC Purchaser

from 10-Q 40 pages Royalty Purchase Agreement Dated as of January 6, 2018 Between Antigenics LLC, as Seller and Healthcare Royalty Partners III, L.P., and Certain Affiliated Funds Identified Herein, Collectively as Purchaser

from S-3 3 pages Amendment to Asset Purchase Agreement

from S-3 51 pages Agenus Inc. and , as Trustee Indenture Dated as of ,

from 10-Q 23 pages Stock Purchase Agreement

from 10-K 3 pages Amendment to Notes and Warrants

from S-3/A 30 pages Technology Transfer and Licence Agreement